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Abstract
Background: High cooling rates with vitrification can be achieved through the use of carriers that allow
cryopreservation in fluid volumes < one μl. Open carriers allow direct contact of embryos with liquid nitrogen
(LN2) whereas closed carrier systems sequester the embryo within a sealed system during immersion in LN2. The
use of closed systems may be preferable to reduce the possibility of cross-contamination. In the present study, we
compare open and closed carriers for vitrification of embryos. We also examine their ability to retain embryo
viability during vapor phase transport.
Methods: Frozen one-cell mouse embryos were thawed and randomly allocated to treatment groups. Embryos
were cultured and vitrified at the 8-cell (CL) or at the blastocyst (BL) stage. The cryoloop, an open carrier was
tested against two closed systems, the Cryotip and the HSV straw. Carriers were tested for their ability to maintain
embryo viability when held in the vapor phase of a dry shipper for a period of 96 hours. Outcome parameters
monitored were embryo survival, recovery, subsequent development and signs of DNA damage.
Results: A total of 561 embryos were vitrified. The only parameter significantly affected by the type of carrier was
the percentage of embryos recovered after warming. Vitrification of both CL and BL stage embryos in the Cryotip
resulted in significantly lower recovery rates (P < 0.001). The subsequent developmental parameters were
unaffected by either the carrier or the cell stage. Vapor phase storage for 96 hours under “transport conditions” did
not appear to adversely affect the viability after warming. Quantitative analysis for DNA damage showed that <5%
of cells were TUNEL positive. Interestingly, the overall percent of cells exhibiting DNA damage was lower after CL
stage vitrification (P < 0.001).
Conclusion: This study is one of the first to examine DNA integrity after vitrification on different carriers and at
different cell stages. It also provides insight on relative safety of short term vapor storage of vitrified embryos
during transport. Within the limits of this study we could not detect an adverse effect of vapor storage on
blastomere DNA or other measured outcome parameters.
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Vitrification for human embryo cryopreservation is a
promising technique but requires the use of carriers
that allow ultra-rapid reduction in temperature [1]. To
this end, the volume of fluid during cryopreservation is
often reduced to less than 1 μl through the use of spe-
cially designed vitrification carriers. One such carrier,
the cryoloop, allows direct contact of the embryos with
liquid nitrogen (LN2), resulting in cooling rates of over
20,000°C/min [2]. Moreover, the cryoloop stays
immersed in the LN2 within the cryovial itself. Theoreti-
cal concerns regarding contamination during direct
exposure and storage of cryopreserved samples in LN2
have been raised [3]. The source of microbial and/or
viral contamination could be from the LN2 source itself
or cross-contamination from an infected sample in the
storage dewar.
Although no infections have been demonstrated with
oocyte/embryo storage to date, there is a movement
towards the use of closed vitrification carriers. Several
closed carrier systems, some FDA approved for specific
cell stages, are now commercially available: the Cryotip
(Irvine Scientific, CA, USA), high security vitrification
(HSV) straw (Cryo BioSystem, Paris, France), VitriSafe
(VitriMed, Austria), the Cryopette (Origio, Denmark)
and the Rapid-i ™(Vitrolife Sweden AB). Other vitrifica-
tion approaches include the S3 system [4] and the S3
μS-VTF device [5], which adapt existing FDA approved
products for use during vitrification. Several recent pub-
lications have examined commercially available closed
carriers for human embryo vitrification [6-10].
One concern with closed vitrification carriers is
whether the rate of cooling is sufficient to minimize cell
damage in both cleavage and blastocyst stage embryos.
Another consideration is the ability of vitrified embryos
to sustain viability when held only in the vapor phase
for 3-4 days during transportation. Dry shippers for
transporting embryos are designed to keep the sample
at -150°C in the vapor phase of LN2. Vitrified embryos
in closed carriers are completely sequestered from the
LN2 and are therefore potentially more vulnerable to
temperature variations, especially when stored in vapor
phase versus directly in the LN2 phase. The effective-
ness of different carriers for transporting embryos dur-
ing vapor phase storage has never been evaluated or
compared. Measurement of DNA fragmentation in
embryos upon warming may help to further gauge
environmental effect on embryo quality [11].
The objective of the current investigation was to com-
pare the performance of two closed vitrification carriers,
the HSV straw and the Cryotip, to the open carrier
cryoloop. Positive outcomes, including live births, from
embryos vitrified with the cryoloop have been well-
documented in the literature [12-18]. We performed a
detailed assessment of each carrier for both cleavage
and blastocyst stage vitrification. The effect of vapor
phase storage on embryonic development and DNA
integrity in vitrified embryos was also examined.
Methods
Study Design
The experiments were carried out in two parts. In
experiment 1 we examined the effect of the vitrification
carrier on embryo survival, recovery and subsequent
development. We also looked for signs of DNA damage
within the embryo. We tested embryos vitrified at both
the 8-cell cleavage stage (Day 3) and the blastocyst stage
(Day 5). In experiment 2, our objective was to examine
the effect of vapor phase storage on embryos vitrified in
open and closed carriers. To this end the vitrified
embryos were held in the vapor phase of a dry shipper
for a period of 96 hours to mimic transport. Once again
we assessed embryo survival, developmental characteris-
tics and tested for DNA integrity in the blastomeres.
Commercially available frozen one-cell mouse
embryos (Conception Technologies; San Diego, CA,
USA) were used for all of the above experiments.
Thawed embryos were pooled and cultured at 37°C with
5% CO2 in air in a humidified incubator. The following
morning 2-cell embryos were randomly allocated to
treatment groups and cultured. Embryos were vitrified
at the 8-cell stage (CL) or at the blastocyst stage (BL).
We tested the cryoloop an open carrier (Hampton
Research, Laguna, CA, USA) against two closed vitrifica-
tion carrier systems, the Cryotip (Irvine Scientific, CA,
USA) and the HSV straw (Cryo BioSystem, Paris,
France).
Vitrification of embryos in different carriers
Embryos were exposed to the first vitrification solution
(Vit 1) composed of 7.5% dimethylsulphoxide (DMSO)
and 7.5% ethylene glycol (EG) in basal medium either
for 2 minutes, for cleavage stage embryos, or 3 minutes
for blastocysts. The additional time given for blastocysts
was based on our clinical experience with blastocyst
vitrification ( [19] and unpublished data). Embryos were
then moved to a second vitrification solution (Vit 2)
composed of 15% DMSO/EG, 10 μg/ml Ficoll and 0.65
mol/L sucrose for 45 seconds. The basal medium for
cryoprotectant (CPA) preparation was Global Blastocyst
medium (Life Global, Ontario, Canada) supplemented
with 20% Synthetic Serum Substitute (SSS; Irvine Scien-
tific, USA). All the steps were performed at 37°C. After
the final exposure to CPA, the embryos were quickly
loaded on to the assigned vitrification carrier.
Cryoloop
A thin film of CPA was applied to the cryoloop by first
dipping the loop in Vit 2. Embryos were then picked up
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on the cryoloop. The cryoloop with embryos was imme-
diately immersed in a cryovial pre-filled with LN2.
HSV straw
Embryos were loaded on to the cut-off end of the
microcapillary tube. The embryos were placed in the
gutter close to the open end of the tube in a miniscule
amount of fluid (<0.5 μl). The capillary tube was then
inserted in to a straw. The open end of the straw was
then closed using a heat sealer (Cryo BioSystem, Paris,
France). The straw with embryos was then plunged in
LN2.
Cryotip
Embryos were loaded in the Cryotip carrier as directed
by the vendor. Briefly, with the aid of a connector and a
Hamilton syringe, a small volume of Vit 2 is aspirated
followed by the embryos in Vit 2 then another small
volume of Vit 2. The lower end was carefully heat sealed
and the cover sleeve was slid down. The connector and
syringe were then carefully removed followed by heat
sealing the thicker upper end of the Cryotip. Finally, the
covered Cryotip was plunged directly into LN2 for
vitrification.
Warming and recovery of embryos
Embryos were unloaded from the carrier into warming
solution 1 (WS1) containing 0.25 M sucrose in Global
Blastocyst medium with 20% SSS. After 2 minutes they
were pipetted into warming solution 2 (WS2) containing
0.125 M sucrose for 3 minutes. All warming steps were
performed at 37°C. Embryos were unloaded from the
different carriers as follows: (1) Cryoloop: embryos were
recovered by quickly immersing the loop in WS1.
Embryos displaced from the cryoloop were visualized
with a dissecting scope. (2) HSV: the straw was held in
LN2, while the upper end of the outer sheath was cut
using wire cutters. The inner straw with gutter was
quickly pulled out of the sheath using the handling rod
and immersed in WS1 to unload the embryos. (3) Cryo-
tip: the tip was initially warmed by immersion in a 37°C
water bath for 3 seconds. After drying the outside of the
Cryotip, the sealed end at the top of the tip was cut off
using scissors. A Hamilton syringe was affixed to the
end of the Cryotip using a silicon connector. The metal
cover was pushed upwards to expose the fine Cryotip
containing the embryos. The sealed tip was cut and
embryos were quickly expelled in to WS1.
Embryos were cultured in Global Medium with 10%
SSS at 37°C with 5.5% CO2 in air. Embryos vitrified at
the cleavage stage were allowed to grow for 48 hours
after warming. Their progression to the blastocyst stage
was monitored before termination of the experiment.
Vitrified-warmed blastocysts were kept in culture for 3
hours to assess re-expansion.
Storage of vitrified embryos
In experiment 1, embryos vitrified on the three different
carriers were completely immersed in LN2 and stored in
the liquid phase. In experiment 2, we wanted to com-
pare the effectiveness of the three different carriers for
vapor phase storage as would be necessary during trans-
port of vitrified embryos. The embryos were vitrified as
per the standard protocol using the different carriers
then immersed in LN2. For each carrier, one half of the
vitrified embryos were randomly allocated to be held in
the vapor phase for 96 hours, while the other half
remained immersed in LN2. We tested embryos vitrified
at both the cleavage and blastocyst stage.
DNA Damage
At the conclusion of the experiments, all vitrified-warmed
embryos were assessed for cryo-injury. DNA damage was
assessed at 48 hours for embryos vitrified at the cleavage
stage and grown in culture. For blastocysts the evaluation
was performed 3 hours after warming. The embryos were
rinsed in PBS and fixed in 4% paraformaldehyde for 30
minutes at room temperature. After washing, the embryos
were permeabilized with 0.1% Triton X-100 on ice for 10
minutes followed by two PBS washes. DNA damage in the
embryos was assessed using the In-Situ Cell Death Detec-
tion kit - TMR-Red (Boehringer Mannheim, Minneapolis,
MN). This kit uses TdT-mediated dUTP nick labeling
(TUNEL technique) to detect nuclei with fragmented
DNA. The embryos were incubated with the TUNEL reac-
tion mixture for 60 minutes at 37°C in the dark. Negative
and positive controls were included for each experiment.
The negative controls were non-vitrified embryos. The
positive controls were treated with DNAse for 10 minutes
to induce DNA strand breaks. Embryos were washed three
times, mounted in 4’, 6-diamidino-2-phenylindole (DAPI)
to label all nuclei. Embryos were examined under a fluor-
escent microscope (Olympus) and the images were cap-
tured for analysis. Total cell number per embryo and the
number of cells with DNA damage were tabulated for
each treatment, carrier and vitrification cell stage. The per-
cent DNA damage was calculated for each embryo by
dividing the number of TUNEL positive cells by the total
blastomere count.
Outcome measures and statistical analysis
Main outcome measures were as follows: (a) Recovery;
% of vitrified embryos successfully recovered from the
carrier upon warming (b) Survival; % of recovered
embryos having greater than half of their cells intact
immediately after warming (c) Blastocyst development;
% of vitrified-warmed cleavage stage embryos developing
to blastocyst after 48 hours of culture (d) Re-expansion;
% of vitrified-warmed blastocysts re-expanded 3 hours
after warming (e) Total blastomere number; cell count
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ment (Day 5 for both CL and BL vitrification) (f) DNA
damage at termination of experiment; % of total cells
showing TUNEL labeling.
Statistical analysis was performed using the Stats
Direct program (StatsDirect Ltd, UK). The chi square
and ANOVA tests were used as appropriate. P values of
<0.05 were considered to be significant.
Results
Experiment 1
To compare the effectiveness of the different carriers for
embryo vitrification, 179 cleavage stage embryos (CL)
and 151 blastocysts (BL) were vitrified using the cryo-
loop, the HSV straw or the Cryotip. Figures 1 and 2
depict the morphology of embryos vitrified at cleavage
and blastocyst stages with the different carriers.
Warmed embryos showed little evidence of cell damage.
Table 1 summarizes the results for the different cell
stages at vitrification as well as the three different car-
riers tested. The only parameter that appeared to be sig-
nificantly affected by the type of carrier was the
percentage of embryos recovered after warming. Vitrifi-
cation of both cleavage and blastocyst stage embryos in
the Cryotip resulted in significantly lower recovery rates
(P < 0.001). The subsequent developmental parameters
Figure 1 Cleavage stage embryos vitrified on different carriers and stored in liquid nitrogen. Images taken immediately after warming (A,
C, E) and 48 hours later (B, D, F). A-B: Cryoloop, C-D: HSV straw, E-F: CryoTip.
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expansion (BL vitrified embryos) and overall blastomere
cell count were unaffected by either the carrier or the
initial cell stage. The open versus closed vitrification sys-
tems did not overtly affect the degree of cryo-injury.
The percentage of blastomeres per embryo showing
DNA damage was similar between carriers. However,
there was a significantly higher rate of DNA damage
after vitrification at the blastocyst stage compared to
cleavage stage embryos (P < 0.0001).
Experiment 2
The ability of the different carriers to sustain vitrified
embryo potential when held in the vapor phase was tested
in this experiment. The LN2 shipper routinely used for
transporting embryos was charged overnight with LN2.
Figure 2 Blastocysts vitrified on different carriers and stored in liquid nitrogen. Photographed before vitrification (A, C, E) and three hours
after warming (B, D, F). A-B: Cryoloop, C-D: HSV straw, E-F: CryoTip.
Table 1 Vitrification of cleavage and blastocyst stage embryos using open and closed carriers
Cleavage Stage Vitrification
Carrier Total embryos
(n)
Recovery
(%)
Survival
(%)
Blastocyst formation after
48 hour culture (%)
Total blastomeres
(mean ± SD)
% DNA Damage
(mean ± SD)
Cryoloop 60 100 100 95 81.9 ± 14.0 1.85 ± 2.05
HSV 52 100 100 94 82.5 ± 15.6 2.06 ± 1.50
Cryotip 67 85* 100 98 78.6 ± 17.9 2.12 ± 2.04
Blastocyst Stage Vitrification
Carrier Total embryos
(n)
Recovery
(%)
Survival
(%)
Re-expansion
(%)
Total blastomeres
(mean ± SD)
% DNA Damage **
(mean ± SD)
Cryoloop 44 100 100 100 86.4 ± 25.8 4.36 ± 2.72
HSV 55 100 100 100 85.9 ± 23.7 3.34 ± 2.79
Cryotip 52 75 * 79 79 88.0 ± 19.2 3.41 ± 2.66
* Significantly lower recovery than with other carriers. P = 0.0001.
** Percent DNA damage was higher in embryos vitrified at the blastocyst versus.
cleavage stage (P < 0.0001), regardless of the type of carrier.
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were critically assessed after warming and culture. The
data was compared to that observed with the control
group stored in LN2. A total of 231 vitrified embryos (CL
= 115; BL = 116) were randomly allocated to the different
treatment groups. These data are summarized in Table 2.
For cleavage stage embryos, liquid and vapor phase storage
resulted in comparable survival and blastocyst formation
rates. The type of carrier did not influence these outcome
parameters. The average blastomere counts were also
unaffected by being held in the vapor phase before warm-
ing and extended culture to blastocyst. We were also
unable to detect an overt negative impact of vapor storage
on vitrified blastocysts. Post-warming survival, re-expan-
sion, and total blastomere count were quite similar
between the carriers, independent of storage condition.
Figure 3 compares DNA damage after storage for 96
hours in the vapor phase of LN2 to controls immersed
in LN2. Interestingly, vitrified blastocysts stored in the
liquid phase with the Cryotip showed more DNA
damage than their counterparts held in the vapor phase
(P = 0.004). Incomplete sealing of the Cryotip may have
entrapped LN2 which negatively impacted recovery and
blastomere survival during warming. With vapor storage
before warming, LN2 within the Cryotip would have
had ample time to dissipate. The DNA damage index
was higher in blastocyst versus cleavage stage embryos.
Figure 4 shows examples of vitrified warmed embryos
stained for DNA damage.
Discussion
The current investigation carefully details embryonic
survival and development after vitrification on an open
carrier, the cryoloop, and two closed carriers, the HSV
straw and the Cryotip. All three carriers were effective
for both cleavage and blastocyst vitrification. The Cryo-
tip was a bit more vulnerable to technical difficulties
during recovery. Based on the outcome parameters
designated in this study, holding vitrified embryos in the
vapor phase of LN2 did not result in obvious impair-
ment of development or a significant increase in damage
to cellular DNA. This finding is reassuring, suggesting
that transport of vitrified embryos may be possible with
minimal harm. Clinical outcome data from transported
embryos is still needed to further corroborate these data.
The theoretical risk of cross-contamination in LN2
containers even at -196°C has been widely debated
[3,20]. Even if source LN2 is sterile, it can become con-
taminated by various routes including handling or con-
tact with infectious samples. The new European
Directive on tissue storage, as well as FDA require-
ments, for new cryopreservation devices mandate the
use of closed systems to negate any risk of microbial or
viral contamination. To date there are only a few com-
mercially available closed carriers for vitrification, the
Cryotip [6,7], the HSV straw [8], VitriSafe [9], the
Cryopette [10] and more recently the Rapid-i™ [21].
This latter system is modeled after the cryoloop, where
the embryo is placed in a miniscule drop suspended in
an open hole on a cylindrical stick, which then can be
completely enclosed and sealed, so there is no direct
contact with LN2.
One of the concerns with the closed carrier systems is
the slower rate of cooling and warming and how this
might affect subsequent outcomes. The cooling rate
with the cryoloop and other open carriers has been
reported to be close to -20,000°C/min [6,15,22]. The
cooling rate with the Rapid-i™device has been
Table 2 Short term vapor storage of vitrified embryos on different carriers to simulate transport conditions
Cleavage Stage Vitrification
Carrier Cryoloop
(n = 40)
HSV Straw
(n = 35)
Cryotip
(n = 40)
Storage Condition LN2 Vapor LN2 Vapor LN2 Vapor
Survival (%) 100 100 100 100 100 100
Development to blastocyst after 48 hours (%) 100 100 100 93 100 100
Total blastomeres
a (mean ± SD) 82.21 ± 13.28 89.18 ± 18.52 87.20 ± 10.67 88.5 ± 9.55 81.10 ± 14.09 75.53 ± 17.62
Blastocyst Stage Vitrification
Carrier Cryoloop
(n = 41)
HSV straw
(n = 40)
Cryotip
(n = 35)
Storage Condition LN2 Vapor LN2 Vapor LN2 Vapor
Survival (%) 100 100 100 100 100 100
Re-expansion (%) 90 81 95 85 80 85
Total blastomeres
a (mean ± SD) 108 ± 18 96 ± 19 96 ± 20 90 ± 20 96 ± 4 86 ± 19
a Total cell count at termination of experiment for both Vit-CL and Vit-BL on day 5.
No significant difference in survival, development, re-expansion or cell number after short term vapor storage as compared to liquid nitrogen.
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fold higher [21]. Kuwayama et al (2005) reported that
the cooling rates with the open carrier Cryotop and the
closed Cryotip carrier were -23,000°C/min and -12,000°
C/min respectively [6]. Both carriers yielded comparable
post warming blastocyst survival, pregnancy and delivery
rates. Cooling rates for Vitrisafe and the HSV straw are
very similar, in the range of -1300 °C [9]. The authors
suggest that perhaps any decrease in the cooling rate
should be compensated for by a gradual increase in the
intracellular cryoprotectant concentrations.
In the current investigation, no modifications were
made to the vitrification protocol to accommodate
closed versus open carriers. There was no evidence of
poorer survival or developmental parameters as a result
of the slower cooling rates in the closed carriers. DNA
damage in blastomeres was comparable in embryos
vitrified on the open cryoloop and the closed HSV
straw. The Cryotip was more subject to problems during
embryo recovery. A study comparing the Cryotip to the
Cryopette [10] also noted a lower recovery rate, (81%
versus 100%, respectively).
It has been suggested that the warming rate may actu-
ally play a more dominant role in modulating survival
rates after vitrification than the cooling rate [23]. These
investigators subjected oocytes to different cooling and
warming rates during the vitrification procedure.
Regardless of the cooling rate, oocyte survival could be
reduced to 0% if the warming rate was at the lowest
level. In contrast, survival was over 80% if the highest
% Apoptosis 
Storage  of Vitrified Embryos and Apoptosis
0 10 20 30
CLV Cryoloop  LN
CLV Cryoloop VP
CLV HSV LN
CLV HSV VP
CLV Cryotip LN
CLV Cryotip VP
BL Cryoloop LN
BL Cryoloop VP
BL HSV LN
BL HSV VP
BL Cryotip LN
BL Cryotip VP
min < limit -[ lower quartile - median - upper quartile ]- limit > max
*
Percent DNA damage
Figure 3 Cleavage and blastocyst stage embryos were vitrified in different carriers and stored in liquid nitrogen (LN) or held in the
vapor phase (VP) of a liquid nitrogen dry shipper for 96 hours to simulate transport conditions. Upon warming, DNA damage was
assessed by quantification of the percentage of blastomeres per embryo exhibiting DNA fragmentation. The only carrier to exhibit a difference
was the Cryotip, with a significantly higher percentage of DNA damage with blastocyst storage in the liquid phase. *P = 0.004. The percentage
of DNA damage was significantly higher with vitrification of blastocysts versus cleavage stage embryos (P < 0.001).
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cooling rate. The authors conclude that too slow warm-
ing is lethal to cells, allowing tiny ice crystal formation.
This may in part explain why closed carrier systems
with their slower cooling rates can still be successfully
applied, as long as the design parameters allow for suffi-
ciently fast warming rates. The few published studies
comparing pregnancy outcomes using open versus
closed vitrification systems suggest that both can be
equally effective [6,9].
Cryopreservation induced stress results in an increase
in apoptotic gene expression, DNA fragmentation and
reduces developmental capacity [11]. In the current
study, DNA damage in vitrified-warmed blastocysts ran-
ged from an average of 1.9% to 4.7%. In contrast,
embryos vitrified at the 8-cell stage and subsequently
warmed and cultured to blastocyst were observed to
have a lower percentage of blastomeres with damaged
DNA, less than 2% (P < 0.0001). With cleavage stage
vitrification, the damaged cell(s) represent a very small
Figure 4 Fluorescent micrographs with representative images of DNA damage detected in vitrified-warmed mouse blastocysts. Nuclei
of blastomeres stained with DAPI showing blue fluorescence. Nuclei with DNA strand breaks were labeled using the TUNEL assay. Damaged
cells bound TMR-red dUTP and exhibited red fluorescence. A-C: Blastocysts vitrified on CryoTip and stored in LN2. TUNEL staining was performed
3 hours after warming. D-E: Blastocysts vitrified on CryoTip and stored in vapor phase under transport conditions. Stained 3 hrs post warming. G-
Blastocyst vitrified on cryoloop and stored in LN2 (3 hrs post warming). H-Cleavage stage embryo vitrified on cryoloop and stored in LN2. TUNEL
labeling 48 hours after warming.
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eral cleavages and reaches the blastocyst stage two days
later. We attribute the wider range of DNA damage dur-
ing blastocyst vitrification to differences in blastocoel
shrinkage after exposure to vitrification solutions (VS).
Despite the fact that all blastocysts were fully expanded
at the time of vitrification, their response to VS solu-
tions varied. Some collapsed immediately while others
still had some blastocoelic fluid at the end of the incu-
bation period before loading on to the carriers. Mechan-
ical blastocoelic fluid reduction prior to vitrification has
been suggested by several studies as an effective techni-
que tool for maximizing blastocyst post-warming survi-
val [14,24-27] and reducing DNA damage [27].
Short term vapor storage for transport as well as long
term storage of cryopreserved samples in the LN2 vapor
phase has been an area of much interest. Vapor storage
has been applied to cryopreserved human sperm [28,29],
mouse embryos vitrified on EM grids [30] and human
oocytes vitrified on the Cryotop [31]. In the latter study,
live birth rates were shown to be unaffected by storage
method. All of the studies concluded that vapor phase sto-
rage was as efficient as liquid phase storage. Vapor phase
storage has been proposed as a means to circumvent the
risk of sample cross-contamination, especially where open
vitrification carriers are stored directly in LN2.
However, a recent study suggests that storage in the
vapor phase still presents an inherent risk for pathogen
transmission and cross-contamination [32]. Ultimately,
only a closed, sealed cryopreservation system can ensure
risk-free storage of samples. Reproductive laboratories
will need to transition to such systems.
Conclusions
In conclusion, this study is one of the first to examine
DNA integrity after vitrification on different carriers and
at different cell stages. It also provides insight on the
relative safety of short term vapor storage of vitrified
embryos during transport. Within the limits of this
study we could not detect an adverse effect of vapor sto-
rage on blastomere DNA or other measured outcome
parameters. A further limitation of this work was the
use of frozen mouse embryos. Monitoring of outcomes
with vitrified human embryos that have been trans-
ported between clinics is imperative to fully appreciate
the risks associated with vapor phase storage. The cur-
rent data set adds to the pool of knowledge on closed
vitrification systems and their efficacy in allowing cool-
ing at sufficient rates to successfully vitrify embryos at
both early and late stages.
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